Skip to main content
Haematologica logoLink to Haematologica
. 2022 Dec 1;107(12):2990. doi: 10.3324/haematol.2022.281988

Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation

Ivan Dlouhy 1,2, Marc Armengol 3,4, Clara Recasens-Zorzo 2, Marcelo L Ribeiro 3,5, Patricia Pérez-Galán 2, Francesc Bosch 6, Armando López-Guillermo 1,2, Gaël Roué 3,
PMCID: PMC9713549  PMID: 36453521

Published under a CC BY-NC license

Erratum to ms. HAEMATOL/2020/278258. “Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-kB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation” Haematologica. 2021 Oct 1;106(10):2749-2753. doi: 10.3324/haema-tol.2020.278258. PMID: 33979991; PMCID: PMC8485659.

Gaël Roué, as corresponding author of the above-referenced article, declares that the request for an addition of a new affiliation for one of the authors (M. Armengol) has been approved by all co-authors. This modification is a prerequisite of Barcelona Autonomous University’s Doctorate program to enable the inclusion of this work in the doctoral thesis of M. Armengol.


Articles from Haematologica are provided here courtesy of Ferrata Storti Foundation

RESOURCES